This report provides all the information you require to better understand Bayer and its partnering interests and activities over the past seven years.

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals. 

Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday.

Bayer is a top pharmaceutical company based in Leverkusen, Germany

Bayer is offering to swap its animal health assets for Merck & Co Inc’s consumer healthcare business, people familiar with the matter said on Tuesday, in a move that could give the German drugmaker a leg up in the $14 billion auction of the Merck business.

Bayer  has proposed to pay $2.4 billion for Norway’s Algeta, its partner for a new prostate cancer treatment, at a 27 percent premium to the stock’s last close, Algeta said on Tuesday.

Bayer is a top pharma company active in partnering, licensing and M&A in pharmaceuticals, agricultural and material sciences

Bayer has announced 5 M&A deals since 2005, with the lead deals being the acquisition of Schiff Nutrition and AgraQuest

Bayer announced over 190 partnering / licensing deals since 2005, with 23 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, cardiovascular, hematology, infectives, central nervous system, gynecology and metabolic diseases

Bayer,  a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years

The biggest bio news hovering the pharmaceutical market is Bayer’s much rumored sale of its blood glucose meter business to French healthcare company Sanofi SA

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx

Genedata announced a collaboration with Bayer Pharma to develop a new workflow management system to support the automation of the Cell Line Development (CLD) process for mammalian cells used to produce biopharmaceuticals

Bayer HealthCare and Aronora announced its strategic alliance to manufacture Aronora’s AB-022 compound for the treatment of cardiovascular diseases

X-Chem has licensed a second drug discovery program to Bayer Pharma pursuant to the multi-target collaboration the companies established in July 2012

Bayer HealthCare and Kyoto University’s Office of Society-Academia Collaboration for Innovation pharma partners by signing a two-year agreement to jointly identify candidates for possible collaborative research projects.

MetaSysX announce the closure of a pharma deal with Bayer CropScience for the coming three years to apply its metabolomics technologies for improving agricultural productivity.

Big pharma Bayer will spin off its plastics unit as the company moves further toward focusing solely on the life sciences market.

Quantum Materials acquires  five diverse sets of patent families from Bayer Technology Services.

Big pharma, Bayer announced a $100,000 donation to the American Red Cross to support the organization’s national disaster and emergency preparedness efforts across the United States.

Big Pharma, Bayer presented New York City Police Commissioner William J. Bratton with a $50,000 donation to the Police Athletic League of New York City in support of its STEM (science, technology, engineering and mathematics) educational programs.